- JP-listed companies
- FRONTEO,Inc.
- Financials
- Return on equity (%)
FRONTEO,Inc. (2158)
Market cap
¥32B
P/E ratio
51.9x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
| Period End | Return on equity (%) (Million JPY) | YoY (%) |
|---|---|---|
| Mar 31, 2025 | 18.3 | -125.39% |
| Mar 31, 2024 | -72.1 | +143.40% |
| Mar 31, 2023 | -29.6 | -225.41% |
| Mar 31, 2022 | 23.6 | +156.35% |
| Mar 31, 2021 | 9.2 | -139.99% |
| Mar 31, 2020 | -23 | -1756.83% |
| Mar 31, 2019 | 1.4 | -107.97% |
| Mar 31, 2018 | -17.4 | -10.37% |
| Mar 31, 2017 | -19.5 | +403.10% |
| Mar 31, 2016 | -3.9 | -164.61% |
| Mar 31, 2015 | 6 |